A

Arthur D. Levinson

American molecular biologist, biochemist and chairman of Apple Inc. (born 1950)

Arthur D. Levinson (born March 31, 1950) is an American businessman who is the lead independent director of Apple Inc. (2026–present) and chief executive officer (CEO) of Calico (an Alphabet Inc. venture). He is the former CEO (1995–2009) and chairman (1999–2014) of Genentech, and the former chairman (2011–2026) of Apple Inc. In addition to serving on the board of Apple Inc. (2000–present), Levinson is on the board of directors of the Broad Institute.

Nº Q709063 ★★★

Rare · People

Arthur D. Levinson

American molecular biologist, biochemist and chairman of Apple Inc. (born 1950)

Arthur D. Levinson (born March 31, 1950) is an American businessman who is the lead independent director of Apple Inc. (2026–present) and chief executive officer (CEO) of Calico (an Alphabet Inc. venture). He is the former CEO (1995–2009) and chairman (1999–2014) of Genentech, and the former chairman (2011–2026) of Apple Inc. In addition to serving on the board of Apple Inc. (2000–present), Levinson is on the board of directors of the Broad Institute.

Last price

—

Floor price

—

7-day median

—

30-day sales

0

30-day range

—

In circulation

0

Price history

Show table
Datemedian LowHighsales

Sales history

Last sale
—
30-day average
—
30-day low
—
30-day high
—
Sales 7d
0
Sales 30d
0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

№ Numbered editions · 0 minted Next #1 · Score ×3
From Wikipedia

Arthur D. Levinson (born March 31, 1950) is an American businessman who is the lead independent director of Apple Inc. (2026–present) and chief executive officer (CEO) of Calico (an Alphabet Inc. venture). He is the former CEO (1995–2009) and chairman (1999–2014) of Genentech, and the former chairman (2011–2026) of Apple Inc. In addition to serving on the board of Apple Inc. (2000–present), Levinson is on the board of directors of the Broad Institute. Previously, Levinson had been on the board of directors at Hoffmann-La Roche (2010–2014), NGM Biopharmaceuticals (2009–2014), and Amyris Biotechnologies (2009–2014). He is on the Board of Scientific Consultants of the Memorial Sloan Kettering Cancer Center, the Industrial Advisory Board of the California Institute for Quantitative Biosciences (QB3), the advisory council for the Princeton University Department of Molecular Biology and the advisory council for the Lewis-Sigler Institute for Integrative Genomics.

Text: Wikipédia, CC BY-SA 4.0. ·

Related cards

View card

Confirmation